Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
ClearPoint Neuro Inc (NASDAQ: CLPT) closed the day trading at $17.52 down -7.79% from the previous closing price of $19.0. In other words, the price has decreased by -$7.79 from its previous closing price. On the day, 1.23 million shares were traded. CLPT stock price reached its highest trading level at $18.5395 during the session, while it also had its lowest trading level at $17.15.
Ratios:
For a better understanding of CLPT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.45 and its Current Ratio is at 7.30. In the meantime, Its Debt-to-Equity ratio is 1.80 whereas as Long-Term Debt/Eq ratio is at 1.78.
On October 24, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 10 ’25 when BURNETT JOSEPH sold 26,463 shares for $26.98 per share. The transaction valued at 714,021 led to the insider holds 217,059 shares of the business.
JOSEPH M BURNETT TRUST bought 26,463 shares of CLPT for $766,368 on Oct 10 ’25. On Jun 10 ’25, another insider, Richards Timothy T., who serves as the Director of the company, sold 10,000 shares for $13.28 each. As a result, the insider received 132,800 and left with 77,381 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLPT now has a Market Capitalization of 498048352 and an Enterprise Value of 491963360. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.83 while its Price-to-Book (P/B) ratio in mrq is 25.22. Its current Enterprise Value per Revenue stands at 14.645 whereas that against EBITDA is -22.729.
Stock Price History:
The Beta on a monthly basis for CLPT is 1.00, which has changed by 0.42002988 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, CLPT has reached a high of $30.10, while it has fallen to a 52-week low of $9.76. The 50-Day Moving Average of the stock is -7.48%, while the 200-Day Moving Average is calculated to be 19.81%.
Shares Statistics:
Over the past 3-months, CLPT traded about 903.95K shares per day on average, while over the past 10 days, CLPT traded about 996370 shares per day. A total of 28.42M shares are outstanding, with a floating share count of 24.37M. Insiders hold about 14.27% of the company’s shares, while institutions hold 33.17% stake in the company. Shares short for CLPT as of 1760486400 were 2382063 with a Short Ratio of 2.64, compared to 1757894400 on 2368518. Therefore, it implies a Short% of Shares Outstanding of 2382063 and a Short% of Float of 8.68.
Earnings Estimates
The dynamic stock of ClearPoint Neuro Inc (CLPT) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.18 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$0.8 and -$0.81 for the fiscal current year, implying an average EPS of -$0.81. EPS for the following year is -$0.68, with 2.0 analysts recommending between -$0.67 and -$0.68.
Revenue Estimates
2 analysts predict $9.6M in revenue for. The current quarter. It ranges from a high estimate of $9.9M to a low estimate of $9.3M. As of. The current estimate, ClearPoint Neuro Inc’s year-ago sales were $8.12MFor the next quarter, 2 analysts are estimating revenue of $10.35M. There is a high estimate of $10.7M for the next quarter, whereas the lowest estimate is $10M.
A total of 2 analysts have provided revenue estimates for CLPT’s current fiscal year. The highest revenue estimate was $38.3M, while the lowest revenue estimate was $37M, resulting in an average revenue estimate of $37.65M. In the same quarter a year ago, actual revenue was $31.39MBased on 2 analysts’ estimates, the company’s revenue will be $47.25M in the next fiscal year. The high estimate is $50.3M and the low estimate is $44.2M.
